Cargando…

Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia

INTRODUCTION: Reporting is an essential component of efforts to combat the distribution and circulation of substandard and falsified (SF) medical products worldwide. However, little is known about why health care professionals (HCPs) do not report suspect products to the national medicine regulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagnild, Janelle M., Lee, Diana, Jayeola, Babatunde, Lukito, Penny K., Fimbo, Adam, Hampshire, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461706/
https://www.ncbi.nlm.nih.gov/pubmed/37640491
http://dx.doi.org/10.9745/GHSP-D-23-00034
_version_ 1785097896707751936
author Wagnild, Janelle M.
Lee, Diana
Jayeola, Babatunde
Lukito, Penny K.
Fimbo, Adam
Hampshire, Kate
author_facet Wagnild, Janelle M.
Lee, Diana
Jayeola, Babatunde
Lukito, Penny K.
Fimbo, Adam
Hampshire, Kate
author_sort Wagnild, Janelle M.
collection PubMed
description INTRODUCTION: Reporting is an essential component of efforts to combat the distribution and circulation of substandard and falsified (SF) medical products worldwide. However, little is known about why health care professionals (HCPs) do not report suspect products to the national medicine regulatory authority (NMRA) and what measures might address this. This pilot study aimed to assess the utility of a smartphone application for reporting SF medical products in Tanzania and Indonesia. METHODS: At baseline, in 2017, HCPs completed a survey describing perceived barriers to reporting and received training in the identification of SF products and received use of the smartphone reporting application (N=309). The application reporting system was piloted for 6 months. Evaluations took place with HCPs and NMRA staff at the midpoint and endline of the pilot study (2018). RESULTS: At baseline, HCPs surveyed (n=254) identified the following key barriers to reporting: difficulties identifying SF products, frustrations with existing reporting systems, and fears that reporting may have personal or reputational repercussions. During the pilot period, HCPs submitted a total of 36 reports of 27 products to the NMRAs in their respective countries; of these, 8 products were determined to be SF and 2 were unregistered. In all 10 cases, appropriate regulatory action was taken. Feedback from HCPs and NMRA staff was positive in both countries, suggesting that the application addressed several barriers to reporting as it was convenient and, importantly, opened a line of communication between HCPs and the NMRA. However, the application did not address all barriers to reporting, such as concerns of repercussions. CONCLUSION: The findings suggest that this smartphone application may be useful for improving HCPs’ reporting of suspected SF products. Developing and piloting similar reporting applications in other countries and contexts is required.
format Online
Article
Text
id pubmed-10461706
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-104617062023-08-29 Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia Wagnild, Janelle M. Lee, Diana Jayeola, Babatunde Lukito, Penny K. Fimbo, Adam Hampshire, Kate Glob Health Sci Pract Short Report INTRODUCTION: Reporting is an essential component of efforts to combat the distribution and circulation of substandard and falsified (SF) medical products worldwide. However, little is known about why health care professionals (HCPs) do not report suspect products to the national medicine regulatory authority (NMRA) and what measures might address this. This pilot study aimed to assess the utility of a smartphone application for reporting SF medical products in Tanzania and Indonesia. METHODS: At baseline, in 2017, HCPs completed a survey describing perceived barriers to reporting and received training in the identification of SF products and received use of the smartphone reporting application (N=309). The application reporting system was piloted for 6 months. Evaluations took place with HCPs and NMRA staff at the midpoint and endline of the pilot study (2018). RESULTS: At baseline, HCPs surveyed (n=254) identified the following key barriers to reporting: difficulties identifying SF products, frustrations with existing reporting systems, and fears that reporting may have personal or reputational repercussions. During the pilot period, HCPs submitted a total of 36 reports of 27 products to the NMRAs in their respective countries; of these, 8 products were determined to be SF and 2 were unregistered. In all 10 cases, appropriate regulatory action was taken. Feedback from HCPs and NMRA staff was positive in both countries, suggesting that the application addressed several barriers to reporting as it was convenient and, importantly, opened a line of communication between HCPs and the NMRA. However, the application did not address all barriers to reporting, such as concerns of repercussions. CONCLUSION: The findings suggest that this smartphone application may be useful for improving HCPs’ reporting of suspected SF products. Developing and piloting similar reporting applications in other countries and contexts is required. Global Health: Science and Practice 2023-08-28 /pmc/articles/PMC10461706/ /pubmed/37640491 http://dx.doi.org/10.9745/GHSP-D-23-00034 Text en © Wagnild et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-23-00034
spellingShingle Short Report
Wagnild, Janelle M.
Lee, Diana
Jayeola, Babatunde
Lukito, Penny K.
Fimbo, Adam
Hampshire, Kate
Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title_full Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title_fullStr Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title_full_unstemmed Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title_short Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
title_sort can a smartphone application help address barriers to reporting substandard/falsified medical products? a pilot study in tanzania and indonesia
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461706/
https://www.ncbi.nlm.nih.gov/pubmed/37640491
http://dx.doi.org/10.9745/GHSP-D-23-00034
work_keys_str_mv AT wagnildjanellem canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia
AT leediana canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia
AT jayeolababatunde canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia
AT lukitopennyk canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia
AT fimboadam canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia
AT hampshirekate canasmartphoneapplicationhelpaddressbarrierstoreportingsubstandardfalsifiedmedicalproductsapilotstudyintanzaniaandindonesia